solifenacin succiate

FDA Drug Profile — Solifenacin Succinate

solifenacin succiate is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Solifenacin Succinate. Available dosage form: tablet, film coated.

Drug Details

Generic Name
solifenacin succiate
Brand Names
Solifenacin Succinate
Application Number
ANDA210281
Sponsor
AvKARE
NDC Codes
2
Dosage Forms
TABLET, FILM COATED
Routes
ORAL
Active Ingredients
SOLIFENACIN SUCCINATE

Indications and Usage

1 INDICATIONS AND USAGE Solifenacin Succinate Tablets are indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Solifenacin Succinate Tablets are a muscarinic antagonist indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.( 1 )